Fast in vivo microextraction: a new tool for clinical analysis.
BACKGROUND
We sought to develop a technique with the potential to partly replace current methods of analysis based on blood draws. To achieve this goal, we developed an in vivo microextraction technique that is faster than conventional methods, interferes minimally with the investigated system, minimizes errors associated with sample preparation, and limits exposure to hazardous biological samples.


METHODS
Solid-phase microextraction devices based on hydrophilic polypyrrole and polyethylene glycol coatings were used for direct extraction of drugs from the flowing blood of beagle dogs, over a period of 8 h. The drugs extracted on the probes were subsequently quantified by liquid chromatography coupled to tandem mass spectrometry. Two calibration strategies--external and standard on the fiber--were used to correlate the amount extracted with the in vivo concentration.


RESULTS
Diazepam and its metabolites were successfully monitored over the course of a pharmacokinetic study, repeated 3 times on 3 beagles. The fast microextraction technique was validated by comparison with conventional plasma analysis, and a correlation factor of 0.99 was obtained. In addition to total concentrations, the method was useful for determining free drug concentrations.


CONCLUSIONS
The proposed technique has several advantages and is suitable for fast clinical analyses. This approach could be used not only for drugs, but for any other endogenous or exogenous compounds.
Musteata
Florin Marcel
FM
Department of Chemistry, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada.
Musteata
Mihaela L
ML
Pawliszyn
Janusz
J
D000818:Animals; D001672:Biocompatible Materials; D001774:Blood Chemical Analysis / Q000295:instrumentation / Q000379:methods*; D001800:Blood Specimen Collection; D002138:Calibration; D002623:Chemistry Techniques, Analytical / Q000295:instrumentation / Q000379:methods*; D002853:Chromatography, Liquid; D003975:Diazepam / Q000097:blood / Q000493:pharmacokinetics; D004285:Dogs; D013058:Mass Spectrometry; D003708:Nordazepam / Q000097:blood / Q000493:pharmacokinetics; D010076:Oxazepam / Q000097:blood / Q000493:pharmacokinetics; D011092:Polyethylene Glycols; D011108:Polymers; D011758:Pyrroles; D012822:Silicon Dioxide
D001672:Biocompatible Materials; D011108:Polymers; D011758:Pyrroles; C067635:polypyrrole; D011092:Polyethylene Glycols; D003708:Nordazepam; D010076:Oxazepam; D012822:Silicon Dioxide; D003975:Diazepam